88 related articles for article (PubMed ID: 1899689)
1. Clearance of t-PA, PAI-1, and t-PA-PAI-1 complex in an isolated perfused rat liver system.
Wing LR; Hawksworth GM; Bennett B; Booth NA
J Lab Clin Med; 1991 Feb; 117(2):109-14. PubMed ID: 1899689
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the interaction of a complex of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 with rat liver cells.
Kuiper J; Otter M; Voorschuur AH; van Zonneveld AJ; Rijken DC; van Berkel TJ
Thromb Haemost; 1995 Nov; 74(5):1298-304. PubMed ID: 8607113
[TBL] [Abstract][Full Text] [Related]
3. A kinetic model of the circulatory regulation of tissue plasminogen activator.
Chandler WL
Thromb Haemost; 1991 Sep; 66(3):321-8. PubMed ID: 1746003
[TBL] [Abstract][Full Text] [Related]
4. Nonlinear pharmacokinetics of tissue-type plasminogen activator in three animal species and isolated perfused rat liver.
Tanswell P; Heinzel G; Greischel A; Krause J
J Pharmacol Exp Ther; 1990 Oct; 255(1):318-24. PubMed ID: 2120422
[TBL] [Abstract][Full Text] [Related]
5. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
6. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
7. Production of tissue-type plasminogen activator (t-PA) and type-1 plasminogen activator inhibitor (PAI-1) in mildly cirrhotic rat liver.
Seki T; Imai H; Uno S; Ariga T; Gelehrter TD
Thromb Haemost; 1996 May; 75(5):801-7. PubMed ID: 8725727
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ
Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178
[TBL] [Abstract][Full Text] [Related]
9. Hepatic clearance of tissue-type plasminogen activator in rats.
Emeis JJ; van den Hoogen CM; Jense D
Thromb Haemost; 1985 Oct; 54(3):661-4. PubMed ID: 3937264
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism or infectious hepatitis.
Tran-Thang C; Fasel-Felley J; Pralong G; Hofstetter JR; Bachmann F; Kruithof EK
Thromb Haemost; 1989 Sep; 62(2):651-3. PubMed ID: 2510345
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activators and plasminogen activator inhibitors in gingival crevicular fluid of cyclosporin A-treated patients.
Buduneli N; Buduneli E; Ciotanar S; Atilla G; Lappin D; Kinane D
J Clin Periodontol; 2004 Jul; 31(7):556-61. PubMed ID: 15191592
[TBL] [Abstract][Full Text] [Related]
12. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
[TBL] [Abstract][Full Text] [Related]
13. [Levels of tissue-type plasminogen activator and plasminogen activator inhibitor 1 in disseminated intravascular coagulation syndrome].
Fukao H; Yamamoto K; Matsuo O
Rinsho Byori; 1991 Jul; 39(7):720-6. PubMed ID: 1920864
[TBL] [Abstract][Full Text] [Related]
14. A kinetic model of the circulatory regulation of tissue plasminogen activator during orthotopic liver transplantation.
Crookston KP; Marsh CL; Chandler WL
Blood Coagul Fibrinolysis; 2000 Jan; 11(1):79-88. PubMed ID: 10691102
[TBL] [Abstract][Full Text] [Related]
15. Total body and hepatic clearance in rats of recombinant tissue-type plasminogen activator expressed in mouse C127 and Chinese hamster ovary cells.
Hori R; He YL; Shima T; Inui K; Aoki S; Okumura K; Tanigawara Y
Drug Metab Dispos; 1992; 20(4):541-6. PubMed ID: 1356732
[TBL] [Abstract][Full Text] [Related]
16. [Quantification of a specific inhibitor (PAI-1) of tissue-type plasminogen activator (t-PA) in the plasma].
Masson C; Angles-Cano E
Ann Biol Clin (Paris); 1989; 47(5):269-74. PubMed ID: 2500878
[TBL] [Abstract][Full Text] [Related]
17. [Plasminogen activator and PAI. Detection in aqueous humor of the human eye].
Steinkamp GW; Hattenbach LO; Heider HW; Scharrer I
Ophthalmologe; 1993 Feb; 90(1):73-5. PubMed ID: 8443455
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasma.
Jørgensen M; Philips M; Thorsen S; Selmer J; Zeuthen J
Thromb Haemost; 1987 Oct; 58(3):872-8. PubMed ID: 3124286
[TBL] [Abstract][Full Text] [Related]
19. Cellular degradation of free and inhibitor-bound tissue-type plasminogen activator--requirement for a co-receptor?
Camani C; Gavin O; Kruithof EK
Thromb Haemost; 2000 Feb; 83(2):290-6. PubMed ID: 10739388
[TBL] [Abstract][Full Text] [Related]
20. Induction of synthesis of plasminogen activator inhibitor type-1 by tissue-type plasminogen activator in human hepatic and endothelial cells.
Fujii S; Lucore CL; Hopkins WE; Billadello JJ; Sobel BE
Thromb Haemost; 1990 Nov; 64(3):412-9. PubMed ID: 2128971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
